American Journal of Transplantation

News and issues that affect organ and tissue transplantation
pp. 437-438(2)
Author: PONDROM, SUE

Arms, Ovaries and Tracheas…What Next?
pp. 438-438(1)

Therapeutic Targets in Liver Transplantation: Angiotensin II in Nonsteatotic Grafts and Angiotensin-(1-7) in Steatotic Grafts
pp. 439-451(13)
Authors: Alfany-Fernandez, I.; Casillas-Ramirez, A.; Bintanel-Morcillo, M.; Brosnihan, K. B.; Ferrario, C. M.; Serafin, A.; Rimola, A.; Rodés, J.; Roselló-Catafau, J.; Peralta, C.

Ex vivo Inhibition of NF-κB Signaling in Alloreactive T-cells Prevents Graft-Versus-Host Disease
pp. 452-462(11)
Authors: O'Shaughnessy, M. J.; Vogtenhuber, C.; Sun, K.; Sitcheran, R.; Baldwin, A. S.; Murphy, W. J.; Dang, L.; Jaffee, B.; Palmer, E.; Serody, J. S.; Blazar, B. R.

Donor and Recipient Origin of Mesenchymal and Endothelial Cells in Chronic Renal Allograft Remodeling
pp. 463-472(10)
Authors: Rienstra, H.; Boersema, M.; Onuta, G.; Boer, M. W.; Zandvoort, A.; van Riezen, M.; Rozing, J.; van Goor, H.; Navis, G. J.; Popa, E. R.; Hillebrands, J. L.

`Chimeric' Grafts Assembled from Multiple Allodisparate Donors Enjoy Enhanced Transplant Survival
pp. 473-482(10)
Authors: Saban, D. R.; Chauhan, S. K.; Zhang, X.; El Annan, J.; Jin, Y.; Dana, R.

The Early Course of Kidney Allograft Rejection: Defining the Time When Rejection Begins
pp. 483-493(11)
Authors: Einecke, G.; Mengel, M.; Hidalgo, L.; Allanach, K.; Famulski, K. S.; Halloran, P. F.

Predictive Ability of Pretransplant Comorbidities to Predict Long-Term Graft Loss and Death
pp. 494-505(12)
Authors: Machnicki, G.; Pinsky, B.; Takemoto, S.; Balshaw, R.; Salvalaggio, P. R.; Buchanan, P. M.; Irish, W.; Bunnapradist, S.; Lentine, K. L.; Burroughs, T. E.; Brennan, D. C.; Schnitzler, M. A.

Effect of Comorbidity Adjustment on CMS Criteria for Kidney Transplant Center Performance
pp. 506-516(11)
Authors: Weinhandl, E. D.; Snyder, J. J.; Israni, A. K.; Kasiske, B. L.

Renal Allografts with IF/TA Display Distinct Expression Profiles of Metzincins and Related Genes
pp. 517-526(10)
Authors: Rödder, S.; Scherer, A.; Raulf, F.; Berthier, C. C.; Hertig, A.; Couzi, L.; Durrbach, A.; Rondeau, E.; Marti, H.-P.

Identifying Specific Causes of Kidney Allograft Loss
pp. 527-535(9)
Authors: El-Zoghby, Z. M.; Stegall, M. D.; Lager, D. J.; Kremers, W. K.; Amer, H.; Gloor, J. M.; Cosio, F. G.

Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term Outcomes
pp. 536-542(7)
Authors: Haririan, A.; Nogueira, J.; Kukuruga, D.; Schweitzer, E.; Hess, J.; Gurk-Turner, C.; Jacobs, S.; Drachenberg, C.; Bartlett, S.; Cooper, M.

Racial Disparity Trends for Graft Failure in the US Pediatric Kidney Transplant Population, 1980-2004
pp. 543-549(7)
Authors: Chavers, B. M.; Snyder, J. J.; Skeans, M. A.; Weinhandl, E. D.; Kasiske, B. L.

Kidney Transplantation Decreases the Level and Procoagulant Activity of Circulating Microparticles
pp. 550-557(8)
Authors: Al-Massarani, G.; Vacher-Coponat, H.; Paul, P.; Arnaud, L.; Loundou, A.; Robert, S.; Moal, V.; Berland, Y.; Dignat-George, F.; Camoin-Jau, L.

ID2-VEGF-related Pathways in the Pathogenesis of Kaposi's Sarcoma: A Link Disrupted by Rapamycin
pp. 558-566(9)
Authors: Stallone, G.; Infante, B.; Pontrelli, P.; Ranieri, E.; Loverre, A.; Schena, A.; Cormio, L.; Carrieri, G.; Schena, F. P.; Grandaliano, G.; Gesualdo, L.

Acute Antibody-Mediated Rejection in Living ABO-Incompatible Kidney Transplantation: Long-Term Impact and Risk Factors
pp. 567-577(11)
Authors: Toki, D.; Ishida, H.; Setoguchi, K.; Shimizu, T.; Omoto, K.; Shirakawa, H.; Iida, S.; Horita, S.; Furusawa, M.; Ishizuka, T.; Yamaguchi, Y.; Tanabe, K.

Kidney Transplantation in Previous Heart or Lung Recipients
pp. 578-585(8)
Authors: Lonze, B. E.; Warren, D. S.; Stewart, Z. A.; Dagher, N. N.; Singer, A. L.; Shah, A. S.; Montgomery, R. A.; Segev, D. L.

Resource Utilization of Living Donor Versus Deceased Donor Liver Transplantation Is Similar at an Experienced Transplant Center
pp. 586-591(6)
Authors: Lai, J. C.; Pichardo, E. M.; Emond, J. C.; Brown Jr., R. S.

¹⁸F-FDG-Uptake of Hepatocellular Carcinoma on PET Predicts Microvascular Tumor Invasion in Liver Transplant Patients
pp. 592-600(9)
Authors: Kornberg, A.; Freesmeyer, M.; Bärthel, E.; Jandt, K.; Katenkamp, K.; Steenbeck, J.; Sappler, A.; Habrecht, O.; Gottschild, D.

Serum Autoantibodies Against Cytochrome P450 2E1 (CYP2E1) Predict Severity of Necroinflammation of Recurrent Hepatitis C
pp. 601-609(9)
Authors: Rigamonti, C.; Vidali, M.; Donato, M. F.; Sutti, S.; Occhino, G.; Ivaldi, A.; Arosio, E.; Agnelli, F.; Rossi, G.; Colombo, M.; Albano, E.

Mycophenolate Mofetil Monotherapy for Severe Side Effects of Calcineurin Inhibitors Following Liver Transplantation
pp. 610-613(4)
Authors: Dharancy, S.; Iannelli, A.; Hulin, A.; Declerck, N.; Schneck, A. S.; Mathurin, P.; Boleslawski, E.; Gugenheim, J.; Pruvot, F. R.

Perceptions of Transitional Care Needs and Experiences in Pediatric Heart Transplant Recipients
pp. 614-619(6)
Authors: Anthony, S. J.; Kaufman, M.; Drabble, A.; Seifert-Hansen, M.; Dipchand, A. I.; Martin, K.

Viral Nucleic Acid Testing (NAT) and OPO-Level Disposition of High-Risk Donor Organs
pp. 620-628(9)
Authors: Kucirka, L. M.; Alexander, C.; Namuyinga, R.; Hanrahan, C.; Montgomery, R. A.; Segev, D. L.

Formal Policies and Special Informed Consent Are Associated with Higher Provider Utilization of CDC High-Risk Donor Organs
pp. 629-635(7)
Authors: Kucirka, L. M.; Namuyinga, R.; Hanrahan, C.; Montgomery, R. A.; Segev, D. L.

Valganciclovir Dosing According to Body Surface Area and Renal Function in Pediatric Solid Organ Transplant Recipients
pp. 636-643(8)
Authors: Vaudry, W.; Ettenger, R.; Jara, P.; Varela-Fascinetto, G.; Bouw, M. R.; Ives, J.; Walker, R.

Follicular Bronchiolitis: A Rare Cause of Bronchiolitis Obliterans Syndrome After Lung Transplantation: A Case Report
pp. 644-650(7)
Authors: Vos, R.; Vanaudenaerde, B. M.; De Vleeschauwer, S. I.; Van Raemdonck, D. E.; Dupont, L. J.; Verbeken, E. K.; De Wever, W.; Verleden, G. M.

Stability of Alemtuzumab for Low-Dose Induction and Test Doses
pp. 651-652(2)